WALTHAM, Mass.--(BUSINESS WIRE)--Avedro, Inc., a privately held medical device and pharmaceutical company, today announced C. Evan Ballantyne as Chief Financial Officer. In this position, Mr. Ballantyne will be responsible for the Company’s financial affairs and report to David Muller, PhD, President and Chief Executive Officer. Prior to this role, Mr. Ballantyne served as Executive Vice President, Chief Financial Officer of Clinical Data, Inc., a biopharmaceutical company which was acquired in April 2011 by Forest Laboratories, Inc. for $1.3 billion.
